Deoxyuridine

Deoxyuridine

SCHEMBL114598

O=c1ccn([C@@H]2C[C@H](O)[C@@H](CO)O2)c(=O)[nH]1

nearest known ligand 0.64

Full drug profile on Sugi Atlas →

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
DUT P33316 3/20 0.64
TK1 P04183 3/20 0.62
LMNA P02545 2/20 0.62
SMN1; SMN2 Q16637 2/20 0.62
SLC28A1 O00337 1/20 0.60
SLC28A2 O43868 1/20 0.60
SLC29A1 Q99808 1/20 0.60
SLC28A3 Q9HAS3 1/20 0.60
ALOX12 P18054 1/20 0.58
ADRA1A P35348 1/20 0.58
TK2 O00142 1/20 0.57
CYP1A2 P05177 1/20 0.56
CYP3A4 P08684 1/20 0.56
TSHR P16473 1/20 0.56
BLM P54132 1/20 0.56
PMP22 Q01453 1/20 0.56
NPSR1 Q6W5P4 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Deoxyuridine SCHEMBL9219261 1.00 DUT (0.64) DUTTK1LMNASMN1; SMN2SLC28A1
Deoxyuridine SCHEMBL2641582 1.00 DUT (0.64) DUTTK1LMNASMN1; SMN2SLC28A1
Deoxyuridine SCHEMBL889540 1.00 DUT (0.64) DUTTK1LMNASMN1; SMN2SLC28A1
Deoxyuridine SCHEMBL19841232 1.00 DUT (0.64) DUTTK1LMNASMN1; SMN2SLC28A1
Deoxyuridine SCHEMBL9708874 1.00 DUT (0.64) DUTTK1LMNASMN1; SMN2SLC28A1
Deoxyuridine SCHEMBL24512520 1.00 DUT (0.64) DUTTK1LMNASMN1; SMN2SLC28A1
Deoxyuridine SCHEMBL4847464 1.00 DUT (0.64) DUTTK1LMNASMN1; SMN2SLC28A1
Deoxyuridine SCHEMBL391224 1.00 DUT (0.64) DUTTK1LMNASMN1; SMN2SLC28A1
Deoxyuridine SCHEMBL9219265 1.00 DUT (0.64) DUTTK1LMNASMN1; SMN2SLC28A1
Deoxyuridine SCHEMBL28844 1.00 DUT (0.64) DUTTK1LMNASMN1; SMN2SLC28A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 4572 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260109728-A1 IMMUNOMODULATING POLYNUCLEOTIDES, ANTIBODY CONJUGATES THEREOF, AND METHODS OF THEIR USE TALLAC THERAPEUTICS INC (US) 2026-04-23 US claimed
US-20250313840-A1 MUCIN-5B (MUC5B) TARGETED SIRNA AND ANTISENSE OLIGONUCLEOTIDES AND METHODS OF USE THEREOF VERTEX PHARMACEUTICALS INCORPORATED (US) 2025-10-09 US claimed
US-20250302925-A1 CONJUGATED CRISPR-CAS COMPLEXES SYNTHEGO CORPORATION 2025-10-02 US claimed
EP-4056711-B1 METHOD FOR GENERATING APTAMERS WITH IMPROVED OFF-RATES SOMALOGIC OPERATING CO INC (US) 2025-09-03 EP claimed
EP-4606903-A1 METHOD FOR ENZYMATIC SYNTHESIS OF NUCLEOSIDE CONTAINING PROTECTING GROUP, AND COMPOSITION Asymchem Life Science (Tianjin) Co., Ltd (CN) 2025-08-27 EP claimed
US-20250263678-A1 COMPOSITIONS AND METHODS FOR DELIVERY OF RNA REJUVENATION TECHNOLOGIES, INC. (US) 2025-08-21 US claimed
US-20250243477-A1 TARGET ENRICHMENT BY UNIDIRECTIONAL DUAL PROBE PRIMER EXTENSION ROCHE SEQUENCING SOLUTIONS INC (US) 2025-07-31 US claimed
US-20250223600-A1 INSULIN RECEPTOR-BINDING APTAMER DIMER AND USE THEREOF POSTECH Research and Business Development Foundation (KR) 2025-07-10 US claimed
US-12351598-B2 Immunomodulating polynucleotides, antibody conjugates thereof, and methods of their use Tallac Therapeutics, Inc. (US) 2025-07-08 US claimed
EP-4578955-A1 METHOD FOR ENZYME-CATALYZED SYNTHESIS OF PURINE NUCLEOSIDE AND COMPOSITION Asymchem Laboratories (Tianjin) Co., Ltd. (CN) 2025-07-02 EP claimed
EP-0351853-B1 Method of manufacturing trifluorothymidine YUKI GOSEI YAKUHIN KOGYO KK (JP) 1994-04-13 EP claimed
EP-0317207-B1 Production of 2,3'-anhydro-2'deoxyuridine derivatives SCOTIA HOLDINGS PLC (GB) 1994-02-02 EP claimed
US-5212161-A Antitumor INSTITUT DE RECHERCHES CHIMIQUES ET BIOLOGIQUES APPLIQUEES (I.R.C.E.B.A.) (FR) 1993-05-18 US claimed
US-5013828-A Fluorinating 2'-deoxyuridine with fluorine gas, fatty acid salt present, acylation with acid anhydride or halide CENTRAL GLASS COMPANY, LIMITED (JP) 1991-05-07 US claimed
EP-0407816-A2 Base modified nucleosides ABBOTT LABORATORIES (US) 1991-01-16 EP claimed
US-4937329-A Production of 2,3'-anhydro-2'-deoxyuridine derivatives EFAMOL HOLDINGS P.L.C. (GB) 1990-06-26 US claimed
EP-0351853-A2 Method of manufacturing trifluorothymidine YUKI GOSEI KOGYO CO., LTD. (JP) 1990-01-24 EP claimed
EP-0343772-A2 Process for preparing platinum green complex AGENCY OF INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) 1989-11-29 EP claimed
EP-0317207-A2 Production of 2,3'-anhydro-2'deoxyuridine derivatives SCOTIA HOLDINGS PLC (GB) 1989-05-24 EP claimed
US-4672111-A 5-azido-deoxyuridine compounds and method of synthesis of the same UNIVERSITY OF WYOMING (US) 1987-06-09 US claimed